Tag: aerpio pharmaceuticals

March 16, 2020

Aerpio Reports Q4 and Full Year 2019 Financial Results

Aerpio Pharmaceuticals reported financial results for the fourth quarter and full year ended December 31, 2019.
January 27, 2019

5 Top Weekly NASDAQ Biotech Stocks: Synergy on Top

Synergy Pharmaceuticals, Alpine Immune Sciences, Aerpio Pharmaceuticals, Correvio Pharma and Athersys were last week's top gainers.
June 26, 2018

Aerpio Pharmaceuticals Announces Uplisting to Nasdaq Capital Market and Pricing of $45.0 Million Public Offering of Common Stock

Aerpio Pharmaceuticals (OTCQB:ARPO) announced that its common stock will begin trading on the Nasdaq Capital Market under the symbol “ARPO”...
June 25, 2018

Aerpio and Gossamer Bio Announce License Agreement

The agreement could bring sales milestones of Aerpio up to US$400 million, including US$20 million as an upfront payment, potential...
June 25, 2018

Aerpio Announces Exclusive License Agreement with Gossamer Bio for AKB-4924

Aerpio Pharmaceuticals (OTCQB:ARPO), announced an exclusive global license agreement with a wholly owned subsidiary of Gossamer Bio, GB004, for the...